Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07475780 · ClinicalTrials.gov registry record · NA
Radiofrequency Ablation For Recurrent Parathyroid Carcinoma
A NA study, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07475780: Recruiting NA study, sponsored by M.D. Anderson Cancer Center.
NCT07475780 is a NA study that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07475780, a NA study, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The study will be an effectiveness study. The study will include enrollment of a total of 20 patients with at least one PC lesion for ultrasound guided RFA to PC recurrence in the neck to assess the effectiveness in reducing patient's hypercalcemia. Patients will have surgically proven PC from prior parathyroidectomy and suspicious PC visible on ultrasound and request for treatment for uncontrolled hypercalcemia (Figure 1).
Interventions
- DEVICE Ultrasound-guided RFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-04-09 |
| Est. Completion | 2031-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07475780
The ClinicalTrials.gov registry entry for NCT07475780 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound-guided RFA is the first listed.
NCT07475780 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07475780 about?
NCT07475780 is a clinical study titled "Radiofrequency Ablation For Recurrent Parathyroid Carcinoma". The study will be an effectiveness study. The study will include enrollment of a total of 20 patients with at least one PC lesion for ultrasound guided RFA to PC recurrence in the neck to assess the effectiveness in reducing patient's hypercalcemia. Patients will have surgically proven PC from prior...
What is the current status of trial NCT07475780?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-04-09. Estimated completion is 2031-04-30.
What interventions are being tested in trial NCT07475780?
The interventions under investigation include: Ultrasound-guided RFA (DEVICE).
Who is sponsoring clinical trial NCT07475780?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.